Transforming growth factor-β1 derived from biliary epithelial cells may attenuate alloantigen-specific immune responses

Transplant International

Volumn 13, Issue 1, 2000, Pages 21-27

  Narumoto, Katsuhiro ^a   Saibara, Toshiji ^b   Maeda, Takashi ^b   Onishi, Saburo ^b   Hayashi, Yoshihiro ^b   Miyazaki, Eriko ^b   Hiroi, Makoto ^b   Enzan, Hideaki ^b   Kobayashi, Nobuaki ^a  

^a EHIME UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Biliary epithelial cells; CTL; Mixed lymphocyte reaction; TGF 1 rat

Indexed keywords

ALLOANTIGEN; ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPITHELIUM CELL; IMMUNE RESPONSE; IMMUNOHISTOLOGY; LIVER TRANSPLANTATION; MALE; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0034126496     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2000.tb01031.x     Document Type: Article

References (28)

1. Bissell DM, Wang SS, Jarnagin WR, Roll FJ (1995) Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 96: 447
2. De Bleser PJ, Niki T, Rogiers V, Geerts A (1997) Transforming growth factor-beta gene expression in normal and fibrotic rat liver. J Hepatol 26: 886
3. Chouaib S, Bensussan A, Termijtelen A, Andreef M, Marchiol-Fournigault C, Fradelizi D, Dupont B (1988) Allogeneic T cell activation triggered by MHC class I antigens. J Immunol 141: 423
4. Egawa H, Martinez OM, Quinn MB (1995) Acute liver allograft rejection in the rat. An analysis of the immune response. Transplantation 59: 97
5. Elwood ET, Larsen CP, Maurer DH (1997) Microchimerism and rejection in clinical transplantation. Lancet 349: 1358
6. Farges O, Morris PJ, Dallman MJ (1994) Spontaneous acceptance of liver allografts in the rat. Analysis of the immune response. Transplantation 57: 171
7. Fink PJ, Weissman IL, Be van MJ (1983) Haplotype specific suppression of cytotoxic T cell induction by antigen inappropriately presented on T cells. J Exp Med 157: 141
8. Howe PH, Draetta G, Leof EB (1991) Transforming growth factor-beta inhibition of phosphorylation and Histone H1 kinase activity is associated with G1/ S-phase growth arrest. Mol Cell Biol 11: 1185
9. Howell CD, De Victor D, Li J, Stephens J, Giorno RC (1995) Liver T cell subsets and adhesion molecules in murine graft-versus-host disease. Bone Marrow Transplantation 16: 139
10. Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Sachs DH (1985) Characterization of mixed allogeneic chimeras: immunocompetence, in-vitro reactivity, and genetic specificity of tolerance. J Exp Med 162: 231
11. Kamada N, Calne RY (1979) Orthotopic liver transplantation in the rat: Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 28: 47
12. Kamada N (1992) Animal models of hepatic allograft rejection. Semin Liver Dis 12: 1
13. Koff A, Ohtsuki M, Polyak K, Roberts JM, Massague J (1993) Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β Science 260: 536
14. Laiho M, DeCaprio JA, Lulow JW, Livingston DM, Massague J (1990) Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation. Cell 62: 175
15. McDonald JC, Adamashvili I, Zibari B (1997) Serologic allogeneic chimerism. Transplantation 64: 865
16. Milani S, Herbst H, Schuppan D, Stein H, Surrenti C (1991) Transforming growth factors β1 and β2 are differentially expressed in fibrotic liver disease. Am J Pathol 139: 1221
17. Miller RG (1980) An immunological suppressor cell inactivates cytotoxic T lymphocyte precursor cells recognizing it. Nature 287: 544
18. Le Moine O, Marchant A, Durand (1994) Systemic release of interleukin-10 during orthotopic livre transplantation. Hepatology 20: 889
19. Muraoka S, Miller RG (1983) Cells in murine fetal liver and in lymphoid colonies grown from fetal liver can suppress generation of cytotoxic T lymphocytes directed against their self antigens. J Immunol 131: 45
20. Pardoux C, Asselin-Paturel C, Chehimi J, Gay F, Mami-Chouaib F, Chouaib S (1997) Functional interaction between TGF-β and IL-12 in human primary allogeneic cytotoxicity and proliferative response. J Immunol 158: 136
21. Rammensee HG, Fink PJ, Bevan MJ (1984) Functional clonal deletion of class I-specific cytotoxic T lymphocytes by veto cells that express antigen. J Immunol 133: 2390
22. Ranges GE, Figari IS, Espevik T, Palladino MA (1987) Inhibition of cytotoxic T cell development by transforming growth factor-beta and reversal by recombinant tumor necrosis factor-alpha. J Exp Med 166: 991
23. Sirica AE, Cihla HP (1984) Isolation and partial characterization of oval and hyperplastic bile ductular cell-enriched populations from the liver of carcinogen and noncarcinogen treated rats. Cancer Res 44: 3454
24. Starzl TE, Demetris AJ, Trucco M (1993) Chimerism after liver transplantation for type IV glycogen storage disease and type IV glycogen storage disease and type I Gaucher's disease. New Engl J Med 328: 745
25. Sun J, McCaughan GW, Matsumoto Y, Sheil AGR, Gallagher ND, Bishop GA (1994) Tolerance to rat liver allografts. I. Differences between tolerance and rejection are more marked in the B cell compared with the T cell or cytokine response. Transplantation 57: 1349
26. Tu Y, Arima T, Flye MW (1997) Rejection of spontaneously accepted rat liver allografts with recipient interleukin-2 treatment or donor irradiation. Transplantation 63: 177
27. Verbanac KM, Carver FM, Haisch CE, Thomas JM (1994) A role for transforming growth-factor beta in the veto mechanism in transplant tolerance. Transplantation 57: 893
28. Wan S, LeClerc JL, Vincent JL (1997) Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann Thorac Surg 63: 269